Last reviewed · How we verify
Rocroniom, Non Depolarizing Muscle Relaxant — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Rocroniom, Non Depolarizing Muscle Relaxant (Rocroniom, Non Depolarizing Muscle Relaxant) — Muhammad Magdy Gaber.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Rocroniom, Non Depolarizing Muscle Relaxant TARGET | Rocroniom, Non Depolarizing Muscle Relaxant | Muhammad Magdy Gaber | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Rocroniom, Non Depolarizing Muscle Relaxant CI watch — RSS
- Rocroniom, Non Depolarizing Muscle Relaxant CI watch — Atom
- Rocroniom, Non Depolarizing Muscle Relaxant CI watch — JSON
- Rocroniom, Non Depolarizing Muscle Relaxant alone — RSS
Cite this brief
Drug Landscape (2026). Rocroniom, Non Depolarizing Muscle Relaxant — Competitive Intelligence Brief. https://druglandscape.com/ci/rocroniom-non-depolarizing-muscle-relaxant. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab